They want to hear it from their own healthcare professionals
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
Hayflick L
Antibacterial conductive self-healing hydrogel wound dressing with dual dynamic bonds promotes infected wound healing
2024;7(6):e2415392
Probiotics and GLP-1 medications can coexist safely in most cases, but timing, strain selection, and individual gut microbiota composition matter significantly